Human Atherosclerotic Plaque Contains Viable Invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis
2005; Lippincott Williams & Wilkins; Volume: 25; Issue: 3 Linguagem: Inglês
10.1161/01.atv.0000155018.67835.1a
ISSN1524-4636
AutoresEmil Kozarov, Brian R. Dorn, Charles E. Shelburne, William A. Dunn, Ann Progulske‐Fox,
Tópico(s)Oral and Maxillofacial Pathology
ResumoHomeArteriosclerosis, Thrombosis, and Vascular BiologyVol. 25, No. 3Human Atherosclerotic Plaque Contains Viable Invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis Free AccessLetterPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissionsDownload Articles + Supplements ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toSupplementary MaterialsFree AccessLetterPDF/EPUBHuman Atherosclerotic Plaque Contains Viable Invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis Emil V. Kozarov, Brian R. Dorn, Charles E. Shelburne, William A. DunnJr and Ann Progulske-Fox Emil V. KozarovEmil V. Kozarov College of Dental Medicine (E.V.K.), Nova Southeastern University, Fort Lauderdale, Fla; Center for Molecular Microbiology (E.V.K., B.R.D., W.A.D., A.P.-F.), Department of Oral Biology and the Periodontal Disease Research Center, College of Dentistry (E.V.K., B.R.D., A.P.-F.), and Department of Anatomy and Cell Biology, College of Medicine (W.A.D.), University of Florida, Gainesville; and University of Michigan School of Dentistry (C.E.S.), Ann Arbor., B.R.D. is currently affiliated with Merchant & Gould, P.C., Minneapolis, Minn. , Brian R. DornBrian R. Dorn College of Dental Medicine (E.V.K.), Nova Southeastern University, Fort Lauderdale, Fla; Center for Molecular Microbiology (E.V.K., B.R.D., W.A.D., A.P.-F.), Department of Oral Biology and the Periodontal Disease Research Center, College of Dentistry (E.V.K., B.R.D., A.P.-F.), and Department of Anatomy and Cell Biology, College of Medicine (W.A.D.), University of Florida, Gainesville; and University of Michigan School of Dentistry (C.E.S.), Ann Arbor., B.R.D. is currently affiliated with Merchant & Gould, P.C., Minneapolis, Minn. , Charles E. ShelburneCharles E. Shelburne College of Dental Medicine (E.V.K.), Nova Southeastern University, Fort Lauderdale, Fla; Center for Molecular Microbiology (E.V.K., B.R.D., W.A.D., A.P.-F.), Department of Oral Biology and the Periodontal Disease Research Center, College of Dentistry (E.V.K., B.R.D., A.P.-F.), and Department of Anatomy and Cell Biology, College of Medicine (W.A.D.), University of Florida, Gainesville; and University of Michigan School of Dentistry (C.E.S.), Ann Arbor., B.R.D. is currently affiliated with Merchant & Gould, P.C., Minneapolis, Minn. , William A. DunnJrWilliam A. DunnJr College of Dental Medicine (E.V.K.), Nova Southeastern University, Fort Lauderdale, Fla; Center for Molecular Microbiology (E.V.K., B.R.D., W.A.D., A.P.-F.), Department of Oral Biology and the Periodontal Disease Research Center, College of Dentistry (E.V.K., B.R.D., A.P.-F.), and Department of Anatomy and Cell Biology, College of Medicine (W.A.D.), University of Florida, Gainesville; and University of Michigan School of Dentistry (C.E.S.), Ann Arbor., B.R.D. is currently affiliated with Merchant & Gould, P.C., Minneapolis, Minn. and Ann Progulske-FoxAnn Progulske-Fox College of Dental Medicine (E.V.K.), Nova Southeastern University, Fort Lauderdale, Fla; Center for Molecular Microbiology (E.V.K., B.R.D., W.A.D., A.P.-F.), Department of Oral Biology and the Periodontal Disease Research Center, College of Dentistry (E.V.K., B.R.D., A.P.-F.), and Department of Anatomy and Cell Biology, College of Medicine (W.A.D.), University of Florida, Gainesville; and University of Michigan School of Dentistry (C.E.S.), Ann Arbor., B.R.D. is currently affiliated with Merchant & Gould, P.C., Minneapolis, Minn. Originally published20 Jan 2005https://doi.org/10.1161/01.ATV.0000155018.67835.1aArteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:e17–e18Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: January 20, 2005: Previous Version 1 To the Editor:Because epidemiological evidence supports an association between cardiovascular and periodontal disease, we assessed whether periodontal pathogens were present in atherosclerotic lesions. To detect invasive bacteria, the natural tropism of the bacteria toward human tissues was exploited. Further, bacterial presence was demonstrated using quantitative polymerase chain reaction (Q-PCR). This confirms the presence of periodontal pathogens in atherosclerotic lesions, whereby the bacteria could contribute to the vascular pathology either directly through their cytotoxicity or indirectly by inducing or exacerbating inflammation.Cardiovascular disease (CVD) is the leading cause of death in the in the United States.1 According to the American Heart Association's statistics from 2003, there were no previous symptoms in 50% of men and 63% of women who died suddenly from CHD. In a 10-year follow-up study, ≈25% of coronary deaths in males and 15% in females occurred in persons in the lowest two quintiles of the multivariate Framingham Heart Study risk scores.2 This and other data have led to an emerging paradigm shift from coronary heart disease having a purely hereditary/nutritional causation to possibly having an infectious component.3Many epidemiological studies strongly suggest that periodontitis may be a risk factor for coronary heart disease (CHD).4 Serologically, edentulousness and serum IgG-antibodies to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in 1163 men were recently shown to be associated with CHD.5 In a larger prospective study of 6950 subjects, the same authors provide serological evidence that an infection caused by major periodontal pathogens is associated with future stroke.6 Previous studies have identified 16S rRNA of oral microbial pathogens, including P gingivalis and A actinomycetemcomitans, in atherosclerotic plaques using PCR.7 However, none of these studies provide evidence that the oral pathogens were viable at the vascular sites.MethodsDetailed Methods are available online at http://atvb.ahajournals.org.ResultsInitially, we confirmed the presence of P gingivalis and A actinomycetemcomitans within the plaque at the first attempt by cell culture invasion assays and immunofluorescent microscopy (Figure). To confirm the findings of the invasion assays and microscopy, additional analyses were performed using Q-PCR. As expected, both organisms were detected using Q-PCR, P gingivalis (at log 4.273 in the DNA sample) and A actinomycetemcomitans (at log 4.779). As ≈one-tenth of the plaque specimen was used for DNA isolation, this analysis indicated the presence of ≈1.9×105P gingivalis and 6.0×105A actinomycetemcomitans in the resected tissue. As the specimen was washed immediately on resection, there is little doubt that the bacteria detected are not a bacteremic carryover from vascular channels or from hemorrhagic material. Control 10 ng of human DNA isolated from peripheral blood leukocytes turned negative in this test, thus demonstrating the primer specificity and the lack of cross-reactivity with the host DNA. Attempts at plating the homogenate on blood agar plates to culture live colonies of P gingivalis were unsuccessful. Therefore, we set out to show that the pathogens from the plaque can invade host cells. As a result, both P gingivalis and A actinomycetemcomitans were detected within ECV-304 cells after incubation with a carotid atherosclerotic plaque homogenate. This indicates that the bacteria from the atherosclerotic plaque were viable because these two species need to be viable to invade nonphagocytic cells according to previous in vitro studies.8,9 In addition, the ECV-304 cells were counterstained with BiP, a lumenal endoplasmic reticulum protein. Some, but not all, A actinomycetemcomitans detected within the ECV-304 cells colocalized with BiP. The detected P gingivalis did not colocalize with BiP. As a control, ECV-304 cells not incubated with the plaque homogenate did not contain bacterial antigens from either species (data not shown). Further, plating lysed ECV-304 cells incubated with carotid atherosclerotic plaques as described above on blood agar plates was unsuccessful. Also unsuccessful were numerous attempts to obtain similar results with frozen plaques (stored in broth with 5% DMSO at −80°C). In terms of contamination, these organisms are fastidious (ie, sensitive to ambient environmental conditions) and thus do not survive under normal laboratory conditions, which makes the possibility of contamination unlikely. Also, the microscopy was performed in another, non-dental research building (University of Florida College of Medicine, Department of Anatomy and Cell Biology, Gainesville).Several pathogens are currently being investigated for a potential role in the pathogenesis of CVD. A strong association exists between CHD and Chlamydia pneumoniae, a Gram-negative respiratory pathogen.10 Several groups have also isolated viable C pneumoniae from atherosclerotic plaques.11–13 Whereas C pneumoniae needs to be transported from the lung to the arteries through macrophages, oral organisms are introduced into the bloodstream multiple times daily in individuals with periodontitis through perturbations of the periodontal tissue such as toothbrushing.14 Therefore, the oral cavity represents a potentially large reservoir of Gram-negative pathogenic organisms that could readily interact with cardiovascular tissues. Indeed, P gingivalis was the predominant species among anaerobic bacteria in bacteremia after dental procedures.15 Further, P gingivalis heat shock protein–specific T-cell lines have been isolated from atheroma lesions,16 which independently supports our data.P gingivalis did not colocalize with BiP, contrary to what would be expected of bacteria that traffic to the autophagic pathway.17 At the time of the experiments, the ECV-304 cells were classified as a human umbilical vein endothelial cell line. Since the time of the experiments, the ECV-304 cells have been identified as a derivative of T24 human bladder epithelial cells. P gingivalis traffics differently in epithelial cells than their intracellular trafficking to the autophagic pathway in endothelial cells.A actinomycetemcomitans escapes its initial vacuoles and is free within the cytoplasm.18 However, cells may use the autophagic machinery to defend against bacteria that escape their vacuoles.19 Thus, the colocalization between A actinomycetemcomitans and BiP may be a result of host cell defense. Therefore, these data are consistent with other studies regarding the in vitro intracellular life cycle of P gingivalis and A actinomycetemcomitans.Detection of periodontal pathogens in atherosclerotic plaques by PCR does not provide evidence as to the bacteria's viability within the plaque. This is the first report to provide evidence for the presence of invasive periodontal pathogens at the sites of atherosclerotic disease. In addition, their presence was demonstrated at the DNA levels. The intracellular bacteria must have been viable because only viable P gingivalis and A actinomycetemcomitans can invade host cells.8,9 Notably, the images presented here are all from the same patient. The patient apparently harbors periodontal organisms, judging from his oral health (partial dentition only). Further investigative work needs to be performed to determine whether periodontal pathogens truly have a role in the pathogenesis of atherosclerotic disease and, if so, how the bacteria contribute to the progression of this disease. Nevertheless, establishing such an unequivocal physical link between these two prevalent conditions will certainly support the notion of periodontitis as an exacerbating factor in cardiovascular pathologies. Identifying the inflammatory bacteria associated with vascular pathogenesis will be beneficial to understanding the epidemiological link between periodontal disease and CVD as well as in developing novel therapies for CVD.Download figureDownload PowerPointDeconvolution micrograph of ECV-304 cells infected with P gingivalis (left) and with A actinomycetemcomitans (right) from a carotid atherosclerotic plaque. P gingivalis is fluorescein isothiocyanate (FITC)-labeled (primary Mab is 61BG1.3) whereas the host cell is TRITC-labeled (primary rabbit anti-BiP antibody). P gingivalis–specific staining is indicated in green, and BiP-, a lumenal endoplasmic reticulum protein, specific staining is indicated in red. Negative control was ECV-304 cells without plaque homogenate inoculation (not shown). The A actinomycetemcomitans is TxR-labeled (primary antibody is purified rabbit IgG fraction against strain SUNY465) whereas the host cell is FITC-labeled with FITC-conjugated goat anti-rabbit BiP. A actinomycetemcomitans–specific staining is indicated in red, and BiP-specific staining is indicated in green. Colocalization of A actinomycetemcomitans and BiP is indicated in yellow because of the overlap of the red- and green-specific staining. Negative control was ECV-304 cells without plaque homogenate inoculation (not shown). Bar, 15 μm.This study was supported by National Institutes of Health (NIH) grants HL72002 (to E.V.K.) and DE13545 (to A.P.-F.), American Heart Association grant 0130455B (to E.V.K.), and by NIH grants DE11117 and DE 007256 (to C.E.S.).1 American Heart Association. Heart Disease and Stroke Statistics: 2004 Update. Dallas, Texas: American Heart Association; 2004.Google Scholar2 Leaverton PE, Sorlie PD, Kleinman JC, Dannenberg AL, Ingster-Moore L, Kannel WB, Cornoni-Huntley JC. Representativeness of the Framingham risk model for coronary heart disease mortality: a comparison with a national cohort study. J Chronic Dis. 1987; 40: 775–784.CrossrefMedlineGoogle Scholar3 Epstein SE, Zhu J, Burnett MS, Zhou YF, Vercellotti G, Hajjar D. Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb Vasc Biol. 2000; 20: 1417–1420.CrossrefMedlineGoogle Scholar4 Beck JD, Pankow J, Tyroler HA, Offenbacher S. Dental infections and atherosclerosis. Am Heart J. 1999; 138: S528–S533.CrossrefMedlineGoogle Scholar5 Pussinen PJ, Jousilahti P, Alfthan G, Palosuo T, Asikainen S, Salomaa V. Antibodies to periodontal pathogens are associated with coronary heart disease. Arterioscler Thromb Vasc Biol. 2003; 23: 1250–1254.LinkGoogle Scholar6 Pussinen PJ, Alfthan G, Rissanen H, Reunanen A, Asikainen S, Knekt P. Antibodies to periodontal pathogens and stroke risk. Stroke. 2004; 35: 2020–2023.LinkGoogle Scholar7 Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques. J Periodontol. 2000; 71: 1554–1560.CrossrefMedlineGoogle Scholar8 Lamont RJ, Chan A, Belton CM, Izutsu KT, Vasel D, Weinberg A. Porphyromonas gingivalis invasion of gingival epithelial cells. Infect Immun. 1995; 63: 3878–3885.CrossrefMedlineGoogle Scholar9 Meyer DH, Sreenivasan PK, Fives-Taylor PM. Evidence for invasion of a human oral cell line by Actinobacillus actinomycetemcomitans. Infect Immun. 1991; 59: 2719–2726.CrossrefMedlineGoogle Scholar10 Campbell LA, Kuo CC, Grayston JT. Chlamydia pneumoniae and cardiovascular disease. Emerg Infect Dis. 1998; 4: 571–579.CrossrefMedlineGoogle Scholar11 Jackson LA, Campbell LA, Kuo CC, Rodriguez DI, Lee A, Grayston JT. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis. 1997; 176: 292–295.CrossrefMedlineGoogle Scholar12 Maass M, Bartels C, Engel PM, Mamat U, Sievers HH. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol. 1998; 31: 827–832.CrossrefMedlineGoogle Scholar13 Ramirez JA. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group. Ann Intern Med. 1996; 125: 979–982.CrossrefMedlineGoogle Scholar14 Silver JG, Martin AW, McBride BC. Experimental transient bacteraemias in human subjects with varying degrees of plaque accumulation and gingival inflammation. J Clin Periodontol. 1977; 4: 92–99.CrossrefMedlineGoogle Scholar15 Messini M, Skourti I, Markopulos E, Koutsia-Carouzou C, Kyriakopoulou E, Kostaki S, Lambraki D, Georgopoulos A. Bacteremia after dental treatment in mentally handicapped people. J Clin Periodontol. 1999; 26: 469–473.CrossrefMedlineGoogle Scholar16 Choi JI, Chung SW, Kang HS, Rhim BY, Kim SJ. Establishment of Porphyromonas gingivalis heat-shock-protein–specific T-cell lines from atherosclerosis patients. J Dent Res. 2002; 81: 344–348.CrossrefMedlineGoogle Scholar17 Dorn BR, Dunn WA, Jr., Progulske-Fox A. Bacterial interactions with the autophagic pathway. Cell Microbiol. 2002; 4: 1–10.CrossrefMedlineGoogle Scholar18 Meyer DH, Rose JE, Lippmann JE, Fives-Taylor PM. Microtubules are associated with intracellular movement and spread of the periodontopathogen Actinobacillus actinomycetemcomitans. Infect Immun. 1999; 67: 6518–6525.CrossrefMedlineGoogle Scholar19 Rich KA, Burkett C, Webster P. Cytoplasmic bacteria can be targets for autophagy. Cell Microbiol. 2003; 5: 455–468.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Hajishengallis G, Li X, Divaris K and Chavakis T (2022) Maladaptive trained immunity and clonal hematopoiesis as potential mechanistic links between periodontitis and inflammatory comorbidities, Periodontology 2000, 10.1111/prd.12421, 89:1, (215-230), Online publication date: 1-Jun-2022. Bregaint S, Boyer E, Fong S, Meuric V, Bonnaure-Mallet M and Jolivet-Gougeon A (2021) Porphyromonas gingivalis outside the oral cavity, Odontology, 10.1007/s10266-021-00647-8, 110:1, (1-19), Online publication date: 1-Jan-2022. Zuo N, Liu W, Hu T, Liu Y, Li B, Liu H, Jing H, Chen X, Li Y, Du J, Hu T, Dong Z, Niu Y and Shi J (2021) Microvesicles, blood cells, and endothelial cells mediate phosphatidylserine‐related prothrombotic state in patients with periodontitis, Journal of Periodontology, 10.1002/JPER.21-0025, 93:2, (289-299), Online publication date: 1-Feb-2022. Hansen P and Holmstrup P (2022) Cardiovascular Diseases and Periodontitis Periodontitis, 10.1007/978-3-030-96881-6_14, (261-280), . El‐Awady A, Elashiry M, Morandini A, Meghil M and Cutler C (2022) Dendritic cells a critical link to alveolar bone loss and systemic disease risk in periodontitis: Immunotherapeutic implications, Periodontology 2000, 10.1111/prd.12428, 89:1, (41-50), Online publication date: 1-Jun-2022. Pussinen P, Kopra E, Pietiäinen M, Lehto M, Zaric S, Paju S and Salminen A (2022) Periodontitis and cardiometabolic disorders: The role of lipopolysaccharide and endotoxemia, Periodontology 2000, 10.1111/prd.12433, 89:1, (19-40), Online publication date: 1-Jun-2022. Jaago M, Pupina N, Rähni A, Pihlak A, Sadam H, Vrana N, Sinisalo J, Pussinen P and Palm K (2022) Antibody response to oral biofilm is a biomarker for acute coronary syndrome in periodontal disease, Communications Biology, 10.1038/s42003-022-03122-4, 5:1, Online publication date: 1-Dec-2022. Song L, Tada H, Nishioka T, Nemoto E, Imamura T, Potempa J, Li C, Matsushita K and Sugawara S (2021) Porphyromonas gingivalis Gingipains-Mediated Degradation of Plasminogen Activator Inhibitor-1 Leads to Delayed Wound Healing Responses in Human Endothelial Cells, Journal of Innate Immunity, 10.1159/000519737, (306-319), . Progulske-Fox A, Chukkapalli S, Getachew H, Dunn W and Oliver J (2022) VBNC, previously unrecognized in the life cycle of Porphyromonas gingivalis? , Journal of Oral Microbiology, 10.1080/20002297.2021.1952838, 14:1, Online publication date: 31-Dec-2022. Iwashita M, Hayashi M, Nishimura Y and Yamashita A (2021) The Link Between Periodontal Inflammation and Obesity, Current Oral Health Reports, 10.1007/s40496-021-00296-4, 8:4, (76-83), Online publication date: 1-Dec-2021. Tang Z, Liang D, Cheng M, Su X, Liu R, Zhang Y and Wu H (2020) Effects of Porphyromonas gingivalis and Its Underlying Mechanisms on Alzheimer-Like Tau Hyperphosphorylation in Sprague-Dawley Rats, Journal of Molecular Neuroscience, 10.1007/s12031-020-01629-1, 71:1, (89-100), Online publication date: 1-Jan-2021. Gianos E, Jackson E, Tejpal A, Aspry K, O'Keefe J, Aggarwal M, Jain A, Itchhaporia D, Williams K, Batts T, Allen K, Yarber C, Ostfeld R, Miller M, Reddy K, Freeman A and Fleisher K (2021) Oral health and atherosclerotic cardiovascular disease: A review, American Journal of Preventive Cardiology, 10.1016/j.ajpc.2021.100179, 7, (100179), Online publication date: 1-Sep-2021. Hajishengallis G (2020) Oral bacteria and leaky endothelial junctions in remote extraoral sites, The FEBS Journal, 10.1111/febs.15510, 288:5, (1475-1478), Online publication date: 1-Mar-2021. Hallikainen J, Keränen S, Savolainen J, Närhi M, Suominen A, Ylöstalo P, Kellokoski J, Pyysalo M, Pussinen P, Rauramaa T and Frösen J (2020) Role of oral pathogens in the pathogenesis of intracranial aneurysm: review of existing evidence and potential mechanisms, Neurosurgical Review, 10.1007/s10143-020-01253-y, 44:1, (239-247), Online publication date: 1-Feb-2021. Sasaki N, Takeuchi H, Kitano S, Irie S, Amano A and Matsusaki M (2021) Dynamic analysis of Porphyromonas gingivalis invasion into blood capillaries during the infection process in host tissues using a vascularized three-dimensional human gingival model , Biomaterials Science, 10.1039/D1BM00831E, 9:19, (6574-6583) Pirih F, Monajemzadeh S, Singh N, Sinacola R, Shin J, Chen T, Fenno J, Kamarajan P, Rickard A, Travan S, Paster B and Kapila Y (2021) Association between metabolic syndrome and periodontitis: The role of lipids, inflammatory cytokines, altered host response, and the microbiome, Periodontology 2000, 10.1111/prd.12379, 87:1, (50-75), Online publication date: 1-Oct-2021. Kayar N, Üstün K, Gözlü M, Haliloğlu S and Alptekin N (2021) The effects of non-surgical periodontal therapy on neutrophil elastase and elastase alpha-1 proteinase inhibitor levels in GCF in periodontitis patients with or without acute coronary syndrome, Clinical Oral Investigations, 10.1007/s00784-021-03838-3, 25:5, (3329-3338), Online publication date: 1-May-2021. Matsushita K (2021) Analysis of Interaction Between Porphyromonas gingivalis and Endothelial Cells In Vitro Periodontal Pathogens, 10.1007/978-1-0716-0939-2_22, (225-233), . Baniulyte G, Piela K and Culshaw S (2021) How strong is the link between periodontitis and stroke?, Evidence-Based Dentistry, 10.1038/s41432-021-0161-7, 22:1, (10-11), Online publication date: 1-Jan-2021. Farrugia C, Stafford G, Potempa J, Wilkinson R, Chen Y, Murdoch C and Widziolek M (2020) Mechanisms of vascular damage by systemic dissemination of the oral pathogen Porphyromonas gingivalis , The FEBS Journal, 10.1111/febs.15486, 288:5, (1479-1495), Online publication date: 1-Mar-2021. Torres M, Gualtero D, Lafaurie G and Fontanilla M (2020) Aggregatibacter actinomycetemcomitans induces a proatherosclerotic response in human endothelial cells in a three‐dimensional collagen scaffold model , Molecular Oral Microbiology, 10.1111/omi.12326, 36:1, (58-66), Online publication date: 1-Feb-2021. Hajishengallis G and Chavakis T (2021) Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities, Nature Reviews Immunology, 10.1038/s41577-020-00488-6, 21:7, (426-440), Online publication date: 1-Jul-2021. Qin X, Zhao Y and Guo Y (2021) Periodontal disease and myocardial infarction risk: A meta-analysis of cohort studies, The American Journal of Emergency Medicine, 10.1016/j.ajem.2021.03.071, 48, (103-109), Online publication date: 1-Oct-2021. Hallikainen J, Pyysalo M, Keränen S, Kellokoski J, Koivisto T, Suominen A, Pussinen P, Pessi T and Frösen J (2021) Systemic immune response against the oral pathogens Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans is associated with the formation and rupture of intracranial aneurysms , European Journal of Neurology, 10.1111/ene.14986, 28:9, (3089-3099), Online publication date: 1-Sep-2021. Yamamoto T and Eguchi T (2020) Heat Shock Proteins and Periodontitis – Cross-Reaction Between Bacterial and Human HSP in Periodontal Infection Linking with Cardiovascular Diseases Heat Shock Proteins in Inflammatory Diseases, 10.1007/7515_2020_24, (19-32), . Chiu C, Chang M, Kantarci A, Van Dyke T and Shi W (2021) Exposure to Porphyromonas gingivalis and Modifiable Risk Factors Modulate Risk for Early Diabetic Retinopathy , Translational Vision Science & Technology, 10.1167/tvst.10.2.23, 10:2, (23), Online publication date: 16-Feb-2021. Jönsson D, Orho‐Melander M, Demmer R, Engström G, Melander O, Klinge B and Nilsson P (2019) Periodontal disease is associated with carotid plaque area: the Malmö Offspring Dental Study (MODS), Journal of Internal Medicine, 10.1111/joim.12998, 287:3, (301-309), Online publication date: 1-Mar-2020. Farrugia C, Stafford G and Murdoch C (2020) Porphyromonas gingivalis Outer Membrane Vesicles Increase Vascular Permeability , Journal of Dental Research, 10.1177/0022034520943187, 99:13, (1494-1501), Online publication date: 1-Dec-2020. Madkour L (2020) Antioxidant Therapeutic Defenses Toward Redox Biology and Oxidative Stress Nanoparticles Induce Oxidative and Endoplasmic Reticulum Stresses, 10.1007/978-3-030-37297-2_12, (557-629), . Frias-Lopez J and Duran-Pinedo A (2020) The Function of the Oral Microbiome in Health and Disease Emerging Therapies in Periodontics, 10.1007/978-3-030-42990-4_10, (141-173), . Nayyar A, Gindina S, Barron A, Hu Y and Danias J (2020) Do epigenetic changes caused by commensal microbiota contribute to development of ocular disease? A review of evidence, Human Genomics, 10.1186/s40246-020-00257-5, 14:1, Online publication date: 1-Dec-2020. Scherer R and Scherer W (2020) U.S. state correlations between oral health metrics and Alzheimer's disease mortality, prevalence and subjective cognitive decline prevalence, Scientific Reports, 10.1038/s41598-020-77937-8, 10:1, Online publication date: 1-Dec-2020. Tossavainen H, Salovaara S, Hellman M, Ihalin R and Permi P (2020) Dispersion from Cα or NH: 4D experiments for backbone resonance assignment of intrinsically disordered proteins, Journal of Biomolecular NMR, 10.1007/s10858-020-00299-w, 74:2-3, (147-159), Online publication date: 1-Mar-2020. Zhong Z, Jin Q, Zhang J, Park Y, Shrestha D, Bai J and Merchant A (2019) Serum IgG Antibodies against Periodontal Microbes and Cancer Mortality, JDR Clinical & Translational Research, 10.1177/2380084419859484, 5:2, (166-175), Online publication date: 1-Apr-2020. Konig M (2020) The microbiome in autoimmune rheumatic disease, Best Practice & Research Clinical Rheumatology, 10.1016/j.berh.2019.101473, 34:1, (101473), Online publication date: 1-Feb-2020. Bescos R, Brookes Z, Belfield L, Fernandez-Sanjurjo M and Casas-Agustench P (2020) Modulation of oral microbiota: A new frontier in exercise supplementation, PharmaNutrition, 10.1016/j.phanu.2020.100230, 14, (100230), Online publication date: 1-Dec-2020. Madkour L (2020) Effects of interactions between antioxidant defense therapy and ROS Reactive Oxygen Species (ROS), Nanoparticles, and Endoplasmic Reticulum (ER) Stress-Induced Cell Death Mechanisms, 10.1016/B978-0-12-822481-6.00023-2, (645-691), . Schenkein H, Papapanou P, Genco R and Sanz M (2020) Mechanisms underlying the association between periodontitis and atherosclerotic disease, Periodontology 2000, 10.1111/prd.12304, 83:1, (90-106), Online publication date: 1-Jun-2020. Seneviratne C, Balan P, Suriyanarayanan T, Lakshmanan M, Lee D, Rho M, Jakubovics N, Brandt B, Crielaard W and Zaura E (2020) Oral microbiome-systemic link studies: perspectives on current limitations and future artificial intelligence-based approaches, Critical Reviews in Microbiology, 10.1080/1040841X.2020.1766414, 46:3, (288-299), Online publication date: 3-May-2020. Liu X, Xu Q, Xiao J, Deng Y, Tang Z, Tang Y and Liu L (2020) Role of oral microbiota in atherosclerosis, Clinica Chimica Acta, 10.1016/j.cca.2020.03.033, 506, (191-195), Online publication date: 1-Jul-2020. Wadhawan A, Reynolds M, Makkar H, Scott A, Potocki E, Hoisington A, Brenner L, Dagdag A, Lowry C, Dwivedi Y and Postolache T Periodontal Pathogens and Neuropsychiatric Health, Current Topics in Medicinal Chemistry, 10.2174/1568026620666200110161105, 20:15, (1353-1397) Brun A, Rangé H, Prouvost B, Mazighi M, Kapila Y, Bouchard P and Michel J (2020) Innovative application of nested PCR for detection of Porphyromonas gingivalis in human highly calcified atherothrombotic plaques , Journal of Oral Microbiology, 10.1080/20002297.2020.1742523, 12:1, (1742523), Online publication date: 1-Jan-2020. Herrera D, Molina A, Buhlin K, Klinge B and Genco R (2020) Periodontal diseases and association with atherosclerotic disease, Periodontology 2000, 10.1111/prd.12302, 83:1, (66-89), Online publication date: 1-Jun-2020. Bobetsis Y, Kotsikoris I, Liapis C, Liasis N, Kakisis J, Kourlaba G, Lazari P, Antonopoulos C, Deliargyris E and Madianos P (2020) Association between periodontal disease and vulnerable plaque morphology in patients undergoing carotid endarterectomy, IJC Heart & Vasculature, 10.1016/j.ijcha.2020.100601, 30, (100601), Online publication date: 1-Oct-2020. Qi J, Zihang Z, Zhang J, Park Y, Shrestha D, Jianling B and Merchant A (2019) Periodontal Antibodies and All-Cause and Cardiovascular Disease Mortality, Journal of Dental Research, 10.1177/0022034519884012, 99:1, (51-59), Online publication date: 1-Jan-2020. Del Pinto R, Pietropaoli D,
Referência(s)